The University of Southampton
University of Southampton Institutional Repository

Venous thromboembolic disease after total hip and knee arthroplasty : current perspectives in a regulated environment

Pellegrini, Vincent, Sharrock, Nigel, Paiement, Guy, Morris, R. and Warwick, David (2008) Venous thromboembolic disease after total hip and knee arthroplasty : current perspectives in a regulated environment In, Duwelius, Paul J. and Azar, Frederick M. (eds.) Instructional Course Lectures. USA, American Academy of Orthopaedic Surgeons pp. 637-661.

Record type: Book Section

Abstract

Venous thromboembolic disease is the single most common reason for readmission to the hospital following total hip and total knee arthroplasty and remains a genuine threat to the life of the patient. Nevertheless, advances in surgical procedure, anesthetic management, and postoperative convalescence have altered the risks of venous thromboembolism after total joint arthroplasty in the lower extremity. Regional anesthetic techniques reduce the prevalence of venographic thrombosis by approximately 50%, and intraoperative monitoring has identified preparation of the femoral canal as the sentinel event that activates the coagulation cascade by the intravasation of marrow fat into the systemic circulation. Prevention of venographic thrombosis is most efficacious by administering fractionated heparin followed by warfarin; warfarin (international normalized ratio 2.0) appears to have a greater safety margin than fractionated heparin based on clinically meaningful bleeding events. Prevention of readmission events, proximal thrombosis, or pulmonary embolism has been demonstrated by using low-intensity warfarin. Aspirin, when used in conjunction with hypotensive epidural anesthesia after hip arthroplasty and regional anesthesia after knee arthroplasty, combined with pneumatic compression devices, also has been suggested to prevent clinical venous thromboembolism, as measured by readmission events. Oral thrombin inhibitors hold promise, but instances of liver toxicity have precluded approval in North America to date. Mechanical compression devices enhance venous flow and increase fibrinolytic activity in the lower extremity; clinical trials demonstrate efficacy in reducing venographic thrombosis alone after total knee arthroplasty and in combination with other chemoprophylactic agents after total hip arthroplasty. Extended chemoprophylaxis for 3 to 6 weeks after surgery is prudent in view of the protracted risk of thrombogenesis and the late occurrence of readmission for venous thrombosis and pulmonary embolism.

Full text not available from this repository.

More information

Published date: 2008

Identifiers

Local EPrints ID: 72741
URI: http://eprints.soton.ac.uk/id/eprint/72741
ISBN: 9780892034147
PURE UUID: db9cd2d9-81ea-467d-b7e8-8f2a756f1bd9

Catalogue record

Date deposited: 23 Feb 2010
Last modified: 18 Jul 2017 23:53

Export record

Contributors

Author: Vincent Pellegrini
Author: Nigel Sharrock
Author: Guy Paiement
Author: R. Morris
Author: David Warwick
Editor: Paul J. Duwelius
Editor: Frederick M. Azar

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×